Clinical Trial Update: The Treatment of Unresectable Liver Cancer With E-TACE Combined With Donafenib：A Prospective, Single-arm, Multicenter, Observational Study

View source ↗

Summary

This document provides an update on a prospective, single-arm observational trial evaluating E-TACE in combination with donafenib for unresectable hepatocellula…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Donafenib (donafenib)

Snippet

Sponsor: Xuhua Duan | Conditions: Carcinoma, Hepatocellular Carcinoma | Status: NOT_YET_RECRUITING